Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Heart Failure - Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
Vertex Pharmaceuticals Incorporated - Telaprevir Presentations at the 59th AASLD Meeting to Feature SVR Data in Treatment-Naive and Treatment-Failure Genotype 1 HCV Patients, and Clinical Data Exploring Twice-Daily Dosing Regimens
Colon Cancer - Reports from P.M. Hoff and colleagues advance knowledge in colon cancer
Cystic Fibrosis - New cystic fibrosis study findings have been reported from Hadassah University
Glioblastoma - Reports summarize glioblastoma research from University of Texas
Glioma - Research findings from T. Sankar et al update understanding of glioma
Lymphoma - Findings in lymphoma reported from V. Murthy and co-researchers
Melanoma - Research from University of Texas in the area of melanoma published
Multiple Sclerosis - Recent findings from M. Gironi and co-authors highlight research in multiple sclerosis
Myeloma - Research from University of Arkansas has provided new data on myeloma
Pharmacokinetics - Research results from Harvard University update knowledge of pharmacokinetics
Alzheimer Disease Clinical Trial - New findings from Saarland University in the area of Alzheimer disease clinical trial described
Cancer Vaccines - Researchers from Copenhagen University, Oncology Center describe findings in cancer vaccines
DNA Research - Research on DNA research detailed by C. Valli and co-authors
Glioblastoma Therapy - New glioblastoma therapy study results reported from Umea University
HIV/AIDS Vaccines - New HIV/AIDS vaccines study results reported from University of Massachusetts, Department of Medicine
Ischemia Therapy - Research from M. Weck and co-researchers provides new data on ischemia therapy
Ophthalmology - Researchers from University of Toronto, Department of Ophthalmology discuss findings in ophthalmology
Pharmacodynamics - Research results from Bayer HealthCare update knowledge of pharmacodynamics
Aeris Therapeutics, Inc. - Kuros and Aeris Announce Exclusive License Agreement in the Field of Lung Volume Reduction
Anthera Pharmaceuticals - Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
Antibiotics - Trius Doses First Patient in Antibacterial Phase 2 Trial
AVEO Pharmaceuticals, Inc. - AVEO Pharmaceuticals Initiates First Clinical Trial of Novel HGF Antagonist in Patients with Advanced Solid Tumors and Lymphomas
Biotech Business - ProFibrix expands Management team and opens US subsidiary
Bristol-Myers Squibb - ERBITUX Five-Year Data Show Significant Improvement in Overall Survival for Patients with Locally or Regionally Advanced Head and Neck Cancer
Cancer - MacroGenics Raises $25M in Series D-2 Financing
Cellerant Therapeutics Inc. - Cellerant Therapeutics Awarded $13.5 Million Contract for Treatment of Acute Radiation Syndrome from the Biomedical Advanced Research and Development Authority BARDA
Concert Pharmaceuticals, Inc. - Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration of CTP-347 and Tamoxifen
Diabetes - DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
Dyax Corp. - Dyax Announces Completion of Biologics License Application for DX-88 for Hereditary Angioedema
Endometriosis - invivodata Captures Symptom Relief Data in Endometriosis Trial
Heart Failure - Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
Hepatitis C Virus - InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
HIV/AIDS - Ambrilia Expands Its Goserelin Product Offering With a Novel One-month Formulation
HIV/AIDS - Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
Hollis-Eden Pharmaceuticals, Inc. - Hollis-Eden Pharmaceuticals Presents Positive Updated Data from Phase I/II Clinical Trial with TRIOLEX in Obese Insulin Resistant Subjects
Hormones - Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
Hormones - Biopartners presents three year safety and efficacy data for sustained release recombinant human growth hormone (LB03002) at ESPE 2008
Hypophosphatasia - Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
Incyte Corporation - Incyte's Topical JAK Inhibitor Demonstrates Positive Proof-of-Concept Results in Patients with Mild to Moderate Psoriasis
Inspire Pharmaceuticals, Inc. - Inspire Initiates Special Protocol Assessment Process for Prolacria Trial for Dry Eye
Intracranial Hemorrhages - Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
ISTA Pharmaceuticals - ISTA Pharmaceuticals Receives $65 Million Funding Commitment
Leukemia - Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
Medgenics - Medgenics, Inc. 'Medgenics' or the 'Company' Half-Yearly Report the Six-Month Period Ended 30 June 2008
Menopause - QuatRx Pharmaceuticals Annonces Additional Data From Phase 3 Study for OPHENA (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
Menopause - QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
Menopause - Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
Merck & Co., Inc. and Japan Tobacco Inc. - Merck & Co., Inc. and Japan Tobacco Inc. Sign Licensing Agreement for Novel Osteoanabolic Drug Candidate to Treat Osteoporosis
Metabasis Therapeutics, Inc. - Metabasis Therapeutics Announces Initiation of a Clinical Trial for MB07803, Its Novel Product Candidate for the Treatment of Type 2 Diabetes
Osiris Therapeutics, Inc. - Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease
Osteosarcoma - IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
Patents - Phosphagenics Announces Initiation of Phase 1 Clinical Trial in Humans for Its Transdermal Lidocaine
Pediatrics - MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Trial of Unit Dose Budesonide in Children with Asthma
Pediatrics - Novel Drug Development Alliance Between Napo Pharmaceuticals and Direct Relief International Targets Global Implications of Pediatric Diarrhea
Pulmatrix Inc. - Pulmatrix Appoints John P. Hanrahan Chief Medical Officer
Type 2 Diabetes - Data from One-Year Liraglutide Phase 3 Study Published Online in the Lancet
Type 2 Diabetes - Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
WFD Ventures - OptiNose presents data on highly effective nasal polyp treatment
